Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3159595rdf:typepubmed:Citationlld:pubmed
pubmed-article:3159595lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3159595lifeskim:mentionsumls-concept:C0026846lld:lifeskim
pubmed-article:3159595lifeskim:mentionsumls-concept:C0242694lld:lifeskim
pubmed-article:3159595lifeskim:mentionsumls-concept:C0677043lld:lifeskim
pubmed-article:3159595pubmed:issue1lld:pubmed
pubmed-article:3159595pubmed:dateCreated1985-8-20lld:pubmed
pubmed-article:3159595pubmed:abstractTextThis study was conducted to examine the histochemical changes occurring due to neonatal 6-mercaptopurine (6-MP) treatment (2 mg/kg, sc, between 2 and 22 days after birth) in the slow-twitch muscle (soleus) of adult male and female rats. At 6 months of age, the control and the 6-MP-treated rats were evaluated for the sciatic nerve conduction to the soleus and for the soleus atrophy and histopathology of the type I (slow-twitch) and type II (fast-twitch) muscle fibers. Compared to the normal controls, the 6-MP-treated male and female rats showed similar sciatic nerve conduction to the soleus. However, there was a significant muscle atrophy (57-60%, P less than 0.01) and a decrease in fiber areas of the type I (42-54%, P less than 0.05) and type II (41-71%, P less than 0.01) fibers. The number of type II fibers declined significantly (7.4-14.8%, P less than 0.05). It is proposed that the soleus muscle atrophy and histopathology in 6-MP-treated rats is unrelated to nerve conduction defects and may be related to growth inhibition caused by an interference of the drug during normal differentiation of muscle fibers.lld:pubmed
pubmed-article:3159595pubmed:languageenglld:pubmed
pubmed-article:3159595pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159595pubmed:citationSubsetIMlld:pubmed
pubmed-article:3159595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3159595pubmed:statusMEDLINElld:pubmed
pubmed-article:3159595pubmed:monthAuglld:pubmed
pubmed-article:3159595pubmed:issn0014-4800lld:pubmed
pubmed-article:3159595pubmed:authorpubmed-author:BalazsTTlld:pubmed
pubmed-article:3159595pubmed:authorpubmed-author:DitunnoJ FJFlld:pubmed
pubmed-article:3159595pubmed:authorpubmed-author:HerbisonG JGJlld:pubmed
pubmed-article:3159595pubmed:authorpubmed-author:JaweedM MMMlld:pubmed
pubmed-article:3159595pubmed:authorpubmed-author:AllevaF RFRlld:pubmed
pubmed-article:3159595pubmed:issnTypePrintlld:pubmed
pubmed-article:3159595pubmed:volume43lld:pubmed
pubmed-article:3159595pubmed:ownerNLMlld:pubmed
pubmed-article:3159595pubmed:authorsCompleteYlld:pubmed
pubmed-article:3159595pubmed:pagination74-81lld:pubmed
pubmed-article:3159595pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:meshHeadingpubmed-meshheading:3159595-...lld:pubmed
pubmed-article:3159595pubmed:year1985lld:pubmed
pubmed-article:3159595pubmed:articleTitleMuscle atrophy and histopathology of the soleus in 6-mercaptopurine-treated rats.lld:pubmed
pubmed-article:3159595pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3159595pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed